Ian Hanson is the founder of Bigfoot Biomedical. Bigfoot Biomedical has raised $212M in total funding. Latest round: M&A. Backed by Abbott Laboratories.
Ian Hanson is the Chief Operating Officer at Bigfoot Biomedical, a diabetes technology company focusing on connected insulin delivery solutions. The company, based in Milpitas, California, was acquired by Abbott in 2023. Hanson provides operational leadership for the development of smart dosing systems like Bigfoot Unity.
Full founder directory · Investor directory · Company funding database · Fundraising library